Skip to content
Medical Health Aged Care, Research Development

Australian Practitioners Set to Benefit from Global Announcement Shaping the Future of 3D Dental Diagnostics

Eyes of AI 2 mins read

Eyes of AI™, a global leader in AI-powered dental imaging, has announced a partnership with W&H, a world-renowned manufacturer of medical technology products and a pioneer in advanced dental equipment.

This partnership marks a major leap forward in AI-driven dental imaging, bringing together Eyes of AI’s state-of-the-art AI segmentation technology with W&H Group’s high-precision imaging equipment. 

Designed with the needs of modern dental practices in mind, the solution combines EAI’s advanced segmentation technology with W&H Group’s leading products to deliver a world-first in dental imaging.

The platform offers real-time visualisation of the mandibular canal and high-resolution 3D mapping of pulp chambers and root canal systems — dramatically improving diagnostic accuracy and treatment planning. It also streamlines workflows with features like automatic nerve tracing, 3D volume alignment, arch line generation, and precise teeth segmentation, offering dentists unprecedented visual clarity and efficiency.

Advanced spatial modelling helps dental practitioners to place implants, perform root canal treatment and remove impacted teeth with precision while patient engagement is enhanced through interactive 3D visualisations, transforming patient consultations and enabling practitioners to demonstrate procedures, treatment options and expected outcomes.

Khoa Le, Co-founder and Chief Executive of Eyes of AI™ said, “The collaboration represents a significant milestone in medical imaging innovation.”

“By combining our AI segmentation technology with the W&H Group’s advanced software, we’re enabling dental professionals to achieve superior patient outcomes through precise diagnostics and treatment planning,” said Khoa.

“Our vision has always been to make a profound difference in the lives of people worldwide and partnering with the W&H Group, an organisation with significant global reach, enables us to do that,” he added.

Valeria Ferrari, Portfolio Director at W&H said, “The future of dental imaging lies in the seamless fusion of advanced hardware and intelligent software. By choosing Eyes of AI, we’re empowering dental professionals with unprecedented clarity and precision in their daily practice.”

W&H will be demonstrating Seethrough at EuroPerio 2025 in Vienna, Austria from 14h - 17th May 2025. 

 


About us:

For more information about Eyes of AI, visit their website here: https://www.eyesofai.com.

For more information about the W&H Group, visit their website here: https://www.wh.com


Contact details:

For media enquiries please contact Alicia Grabowski / Project PR & Media / [email protected] / 0401878496

Media

More from this category

  • Medical Health Aged Care
  • 12/12/2025
  • 10:11
Cosette Pharmaceuticals, Inc.

Termination of Proposed Acquisition of Mayne Pharma

BRIDGEWATER, N.J.–BUSINESS WIRE– Cosette Pharmaceuticals, Inc. (Cosette), a U.S.-based, fully integrated pharmaceutical company, confirms that on 9 December 2025 it served a notice on…

  • Contains:
  • Medical Health Aged Care
  • 12/12/2025
  • 08:55
Royal Australian College of GPs

Universal Health Coverage Day: RACGP calls out need for better funding for chronic conditions and preventive care

Specialist GPs have marked International Universal Health Coverage (UHC) Day by joining the World Health Organization in highlighting the devastating impact of health costs. The Royal Australian College of GPs (RACGP) has stressed that a public health system which forces patients with complex or chronic conditions to pay out of pocket for longer consultations can’t claim to offer universal coverage, and urged governments to protect patients from financial hardship. “Health is a human right,” RACGP President Dr Michael Wright said. “Australia recognises the right of everyone to the highest attainable standard of physical and mental health, and our governments are…

  • Contains:
  • Medical Health Aged Care, Women
  • 12/12/2025
  • 01:00
Breast Cancer Trials

Simple blood tests could help tailor treatment for aggressive breast cancer

Key Facts: Blood tests detecting circulating tumour DNA could help guide treatment for triple negative breast cancer patients Absence of tumour DNA in blood…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.